De-escalation strategies in the management of differentiated thyroid cancer.

Arawker MH; Habibullah F; Baral S; Fu L; Sun N; Li H; Qiu X

doi:10.1007/s12020-026-04563-1

← 뒤로

De-escalation strategies in the management of differentiated thyroid cancer.

0/5 보강

Endocrine 2026 Vol.91(1) p. 85

Arawker MH, Habibullah F, Baral S, Fu L, Sun N, Li H, Qiu X

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Arawker MH, Habibullah F, et al. (2026). De-escalation strategies in the management of differentiated thyroid cancer.. Endocrine, 91(1), 85. https://doi.org/10.1007/s12020-026-04563-1

MLA Arawker MH, et al.. "De-escalation strategies in the management of differentiated thyroid cancer.." Endocrine, vol. 91, no. 1, 2026, pp. 85.

PMID 41697514

DOI 10.1007/s12020-026-04563-1

같은 제1저자의 인용 많은 논문 (1)

Theranostic and Radionuclide-based Treatment Approaches for Radioiodine-refractory Thyroid Cancer: From Biology to Clinical Application.
Molecular imaging and biology 2026